Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pyry A J Välitalo

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Pharmacokinetics|May 9, 2018
Author's Reply to Reith: "Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen"Anne van Rongen, Pyry A J Välitalo, Catherijne A J Knibbe
The AAPS Journal|November 29, 2017
Kernel-Based Visual Hazard Comparison (kbVHC): a Simulation-Free Diagnostic for Parametric Repeated Time-to-Event ModelsSebastiaan C Goulooze, Pyry A J Välitalo, Catherijne A J Knibbe, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 9, 2025
Aggregate data modelling: A fast implementation for fitting pharmacometrics models to summary-level data in RHidde van de Beek, Pyry A J Välitalo, J G Coen van Hasselt, et al.
Pain|January 14, 2016
Pain and distress caused by endotracheal suctioning in neonates is better quantified by behavioural than physiological items: a comparison based on item response theory modellingPyry A J Välitalo, Monique van Dijk, Elke H J Krekels, et al.
Clinical Pharmacokinetics|March 25, 2018
The Influence of Normalization Weight in Population Pharmacokinetic Covariate ModelsSebastiaan C Goulooze, Swantje Völler, Pyry A J Välitalo, et al.
Expert Review of Clinical Pharmacology|June 9, 2016
Children in clinical trials: towards evidence-based pediatric pharmacotherapy using pharmacokinetic-pharmacodynamic modelingJanneke M Brussee, Elisa A M Calvier, Elke H J Krekels, et al.
Clinical Pharmacokinetics|August 12, 2016
Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?Elisa A M Calvier, Elke H J Krekels, Pyry A J Välitalo, et al.
Pharmaceutical Research|December 3, 2015
Structure-Based Prediction of Anti-infective Drug Concentrations in the Human Lung Epithelial Lining FluidPyry A J Välitalo, Koen Griffioen, Matthew L Rizk, et al.
Clinical Pharmacokinetics|May 17, 2017
Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-GlucuronideSjoerd de Hoogd, Pyry A J Välitalo, Albert Dahan, et al.
British Journal of Clinical Pharmacology|January 13, 2017
Dose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysisEsther J H Janssen, Diane E T Bastiaans, Pyry A J Välitalo, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Pharmacokinetics|May 9, 2018
Author's Reply to Reith: "Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen"Anne van Rongen, Pyry A J Välitalo, Catherijne A J Knibbe
The AAPS Journal|November 29, 2017
Kernel-Based Visual Hazard Comparison (kbVHC): a Simulation-Free Diagnostic for Parametric Repeated Time-to-Event ModelsSebastiaan C Goulooze, Pyry A J Välitalo, Catherijne A J Knibbe, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 9, 2025
Aggregate data modelling: A fast implementation for fitting pharmacometrics models to summary-level data in RHidde van de Beek, Pyry A J Välitalo, J G Coen van Hasselt, et al.
Pain|January 14, 2016
Pain and distress caused by endotracheal suctioning in neonates is better quantified by behavioural than physiological items: a comparison based on item response theory modellingPyry A J Välitalo, Monique van Dijk, Elke H J Krekels, et al.
Clinical Pharmacokinetics|March 25, 2018
The Influence of Normalization Weight in Population Pharmacokinetic Covariate ModelsSebastiaan C Goulooze, Swantje Völler, Pyry A J Välitalo, et al.
Expert Review of Clinical Pharmacology|June 9, 2016
Children in clinical trials: towards evidence-based pediatric pharmacotherapy using pharmacokinetic-pharmacodynamic modelingJanneke M Brussee, Elisa A M Calvier, Elke H J Krekels, et al.
Clinical Pharmacokinetics|August 12, 2016
Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?Elisa A M Calvier, Elke H J Krekels, Pyry A J Välitalo, et al.
Pharmaceutical Research|December 3, 2015
Structure-Based Prediction of Anti-infective Drug Concentrations in the Human Lung Epithelial Lining FluidPyry A J Välitalo, Koen Griffioen, Matthew L Rizk, et al.
Clinical Pharmacokinetics|May 17, 2017
Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-GlucuronideSjoerd de Hoogd, Pyry A J Välitalo, Albert Dahan, et al.
British Journal of Clinical Pharmacology|January 13, 2017
Dose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysisEsther J H Janssen, Diane E T Bastiaans, Pyry A J Välitalo, et al.
Pageof 2